{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:12:08Z","timestamp":1792390328167,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.09.013","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T20:47:57Z","timestamp":1663274877000},"page":"922-932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer"],"prefix":"10.1016","volume":"350","author":[{"given":"Li","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikai","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangzhu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.09.013_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.semcancer.2018.02.010","article-title":"Genomics and emerging biomarkers for immunotherapy of colorectal cancer","volume":"52","author":"Kather","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0015","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1040-8428(01)00192-5","article-title":"Oxaliplatin:results in colorectal carcinoma","volume":"44","author":"Carrato","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102112","article-title":"Oxaliplatin retreatment in metastatic colorectal cancer: systematic review and future research opportunities","volume":"91","author":"Mauri","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0030","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1186\/s12885-018-4185-0","article-title":"The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review","volume":"18","author":"Gebremedhn","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2022.09.013_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061370","article-title":"Management of oxaliplatin-induced peripheral sensory neuropathy","volume":"12","author":"Cavaletti","year":"2020","journal-title":"Cancers."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.013_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0055","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal Cancer","volume":"383","author":"Andre","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0060","doi-asserted-by":"crossref","first-page":"8105","DOI":"10.1002\/anie.201500478","article-title":"Hypoxia induced by upconversion-based photodynamic therapy: towards highly effective synergistic bioreductive therapy in tumors","volume":"54","author":"Liu","year":"2015","journal-title":"Angew. Chem."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0065","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00280-006-0224-7","article-title":"Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene","volume":"58","author":"Song","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0070","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1158\/1535-7163.MCT-06-0145","article-title":"Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells","volume":"5","author":"Hussein","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0075","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1158\/1078-0432.CCR-03-0488","article-title":"Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine","volume":"10","author":"Yokoi","year":"2004","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0080","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/ijc.24601","article-title":"Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3","volume":"125","author":"Selvendiran","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.013_bb0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.05.025","article-title":"Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer","volume":"138","author":"Zhang","year":"2017","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0095","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1007\/s12274-016-1274-8","article-title":"Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy","volume":"10","author":"Song","year":"2016","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.11.006","article-title":"Drug-induced co-assembly of albumin\/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy","volume":"263","author":"Chen","year":"2017","journal-title":"J. Controlled Release Off. J. Controll. Release Soc."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.biomaterials.2016.10.020","article-title":"TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy","volume":"112","author":"Song","year":"2017","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0115","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2022.09.013_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002773","article-title":"Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects","volume":"9","author":"Veeramachaneni","year":"2021","journal-title":"J Immunother Cancer."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/onc.2009.356","article-title":"Immunogenic death of colon cancer cells treated with oxaliplatin","volume":"29","author":"Tesniere","year":"2010","journal-title":"Oncogene."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0130","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.immuni.2015.11.024","article-title":"Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy","volume":"44","author":"Pfirschke","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120190","article-title":"Oxaliplatin-\/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer","volume":"255","author":"Shen","year":"2020","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0140","first-page":"1","article-title":"Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0145","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1002\/adfm.201504899","article-title":"Cisplatin-prodrug-constructed liposomes as a versatile theranostic nanoplatform for bimodal imaging guided combination cancer therapy","volume":"26","author":"Feng","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0150","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s12274-020-2972-9","article-title":"Metal-polyphenol-network coated CaCO3 as pH-responsive nanocarriers to enable effective intratumoral penetration and reversal of multidrug resistance for augmented cancer treatments","volume":"13","author":"Dong","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40820-020-00549-4","article-title":"CaCO3-assisted preparation of pH-responsive immune-modulating nanoparticles for augmented chemo-immunotherapy","volume":"13","author":"Zhu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113974","article-title":"Biomembrane-based nanostructures for cancer targeting and therapy: from synthetic liposomes to natural biomembranes and membrane-vesicles","volume":"178","author":"Wang","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0165","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/1078-0432.CCR-13-1787","article-title":"Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response","volume":"19","author":"Zannella","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.013_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-01050-0","article-title":"Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses","volume":"8","author":"Yang","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:38:10Z","timestamp":1759163890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"alternative-id":["S0168365922005971"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.013","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal oxaliplatin prodrugs loaded with metformin potentiate immunotherapy for colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}